• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于持续释放非激素避孕药和抗艾滋病毒药物的阴道环的研发。

Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents.

作者信息

Han Young A, Singh Mukul, Saxena Brij B

机构信息

Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Weill Medical College of Cornell University, 515 East 71st Street, S-412, New York, NY 10021, USA.

出版信息

Contraception. 2007 Aug;76(2):132-8. doi: 10.1016/j.contraception.2007.04.006. Epub 2007 Jun 27.

DOI:10.1016/j.contraception.2007.04.006
PMID:17656183
Abstract

OBJECTIVES

Construction of vaginal rings to deliver nonhormonal contraceptives and 3'-azido-3'-deoxythymidine (AZT) as an anti-HIV agent and determination of their daily release and efficacy in vitro.

MATERIALS AND METHODS

Intravaginal rings of 0.5-0.7 cm rim and 5-5.5 cm in diameter were cast in the molds. The rings were composed of biosoluble acacia gum or nonbiodegradable hydrogel of 2-hydroxyethyl methacrylate (HEMA) and sodium methacrylate (SMA) [P(HEMA-co-SMA)]. The rings were impregnated with nonhormonal contraceptives such as ferrous gluconate to cause spermiostasis, l-ascorbic acid to increase the viscosity of the cervical mucus, and pharmalytes of pH 4-5 or AZT.

RESULTS

The daily release rate of nonhormonal contraceptives as well as AZT from the rings was efficacious in vitro. Cumulative effect of nonhormonal contraceptives showed complete spermiostasis within 30 s up to 10 and 28 days, respectively. Daily release of AZT from both rings was also likely to be efficacious to inhibit HIV proliferation in vitro for 10 and 28 days, respectively.

CONCLUSION

The data indicate that the rings described here can be developed for intravaginal delivery of nonhormonal contraceptives and/or anti-HIV agents.

摘要

目的

构建用于递送非激素避孕药和作为抗HIV药物的3'-叠氮基-3'-脱氧胸苷(AZT)的阴道环,并测定其每日释放量及体外有效性。

材料与方法

在模具中浇铸边缘为0.5 - 0.7厘米、直径为5 - 5.5厘米的阴道环。这些环由生物可溶的阿拉伯胶或由甲基丙烯酸2-羟乙酯(HEMA)和甲基丙烯酸钠(SMA)[P(HEMA-co-SMA)]组成的不可生物降解水凝胶制成。环中浸渍有非激素避孕药,如葡萄糖酸亚铁以导致精子制动、L-抗坏血酸以增加宫颈黏液的黏度,以及pH值为4 - 5的两性电解质或AZT。

结果

非激素避孕药以及AZT从环中的每日释放率在体外是有效的。非激素避孕药的累积效应分别在30秒内直至10天和28天显示出完全的精子制动。两种环中AZT的每日释放在体外分别抑制HIV增殖10天和28天也可能是有效的。

结论

数据表明,此处所述的环可用于开发用于阴道递送非激素避孕药和/或抗HIV药物。

相似文献

1
Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents.用于持续释放非激素避孕药和抗艾滋病毒药物的阴道环的研发。
Contraception. 2007 Aug;76(2):132-8. doi: 10.1016/j.contraception.2007.04.006. Epub 2007 Jun 27.
2
Sustained release of microbicides by newly engineered vaginal rings.新型阴道环的杀微生物剂持续释放。
AIDS. 2009 May 15;23(8):917-22. doi: 10.1097/QAD.0b013e32832af57c.
3
Efficacy of nonhormonal vaginal contraceptives from a hydrogel delivery system.水凝胶给药系统非激素阴道避孕药的疗效
Contraception. 2004 Sep;70(3):213-9. doi: 10.1016/j.contraception.2004.02.015.
4
Stampidine is a potential nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide.斯坦皮定是一种潜在的非杀精广谱抗人类免疫缺陷病毒杀菌剂。
Fertil Steril. 2004 Mar;81 Suppl 1:831-41. doi: 10.1016/j.fertnstert.2003.08.037.
5
Poly(HEMA-Zidovudine) conjugate: a macromolecular pro-drug for improvement in the biopharmaceutical properties of the drug.聚(HEMA-齐多夫定)缀合物:一种用于改善药物生物制药性质的大分子前药。
Drug Deliv. 2011 May;18(4):272-80. doi: 10.3109/10717544.2010.536272. Epub 2010 Nov 26.
6
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings.HIV杀微生物剂TMC120从硅橡胶阴道环的长期控释。
J Antimicrob Chemother. 2005 Nov;56(5):954-6. doi: 10.1093/jac/dki326. Epub 2005 Sep 9.
7
In vivo evaluation of the release of zidovudine and polystyrene sulfonate from a dual intravaginal bioadhesive polymeric device in the pig model.体内评价齐多夫定和聚苯乙烯磺酸钠从猪模型中双阴道生物粘附聚合物装置中的释放。
J Pharm Sci. 2011 Apr;100(4):1416-35. doi: 10.1002/jps.22365. Epub 2010 Oct 19.
8
[Present and future choice of pharmaceutical forms for intravaginal administration. II. Barrier systems and vaginal rings].
J Pharm Belg. 1993 Nov-Dec;48(6):479-90.
9
Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates.用于向非人灵长类动物持续递送HIV杀微生物剂的阴道环装置的研发与评估。
J Med Primatol. 2009 Aug;38(4):263-71. doi: 10.1111/j.1600-0684.2009.00354.x. Epub 2009 May 19.
10
Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.齐多夫定甲氧基聚(乙二醇)碳酸酯前药的合成及其体外经人皮肤的渗透
J Pharm Pharmacol. 2009 Jun;61(6):721-31. doi: 10.1211/jpp.61.06.0004.

引用本文的文献

1
Recent progress in advanced biomaterials for long-acting reversible contraception.长效可逆避孕先进生物材料的最新进展。
J Nanobiotechnology. 2022 Mar 17;20(1):138. doi: 10.1186/s12951-022-01329-5.
2
Development of Hormonal Intravaginal Rings: Technology and Challenges.激素阴道环的研发:技术与挑战
Geburtshilfe Frauenheilkd. 2021 Jul;81(7):789-806. doi: 10.1055/a-1369-9395. Epub 2021 Jul 13.
3
Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications.
将先进的电纺纤维结构与活性剂的时间释放相关联,以满足下一代阴道内给药应用的需求。
Pharmaceutics. 2019 Apr 3;11(4):160. doi: 10.3390/pharmaceutics11040160.
4
In situ-forming and pH-responsive hydrogel based on chitosan for vaginal delivery of therapeutic agents.基于壳聚糖的原位形成和 pH 响应水凝胶用于治疗剂的阴道给药。
J Mater Sci Mater Med. 2018 Oct 22;29(11):158. doi: 10.1007/s10856-018-6166-x.
5
Development and in vitro/in vivo Evaluation of a Silastic Intravaginal Ring for Mifepristone Delivery.用于米非司酮递送的硅橡胶阴道环的研制及体内外评价
Indian J Pharm Sci. 2015 May-Jun;77(3):335-42. doi: 10.4103/0250-474x.159671.
6
Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections.阴道环:用于避孕和预防性传播感染的控释系统。
Drug Deliv Transl Res. 2011 Jun;1(3):185-93. doi: 10.1007/s13346-011-0024-4.
7
The optimization of an intravaginal ring releasing progesterone using a mathematical model.使用数学模型优化释放孕酮的阴道环
Pharm Res. 2014 Mar;31(3):795-808. doi: 10.1007/s11095-013-1201-6. Epub 2013 Oct 18.
8
In search of the optimal delivery method for anti-HIV microbicides: are intravaginal rings the way forward?寻找抗HIV杀微生物剂的最佳给药方式:阴道环是未来的方向吗?
Expert Rev Anti Infect Ther. 2013 Jan;11(1):5-8. doi: 10.1586/eri.12.155.
9
Preparation and evaluation of intravaginal ring containing drospirenone.含屈螺酮阴道环的制备与评价
Adv Pharmacol Sci. 2013;2013:192408. doi: 10.1155/2013/192408. Epub 2013 Jan 17.
10
Drug-eluting fibers for HIV-1 inhibition and contraception.载药纤维抑制 HIV-1 并避孕。
PLoS One. 2012;7(11):e49792. doi: 10.1371/journal.pone.0049792. Epub 2012 Nov 28.